Subscribe to our newsletter

VIDEO: Registries as Sources of Regulatory-Grade RWE

Registries as sources of regulatory-grade RWE and how to choose the one that best suits your needs.

In this video, Dr. Peter Wahl, Global Head of Scientific Affairs at CorEvitas, delves into the purposes of registries, from safety studies to comparative effectiveness research, and highlights the various options available, such as multi-sponsor and bespoke registries. Dr. Wahl also discusses the regulatory perspective on using registries and shares examples of how CorEvitas’ registry data can be used in real-world scenarios. Watch to gain insights on registry selection, regulatory requirements, and the value of registry data in addressing research questions.

Pharmaceutical Exec interview with Peter M Wahl
Click to view video

 

LEARN MORE: How RWE and RWD from registries enhance clinical development